Modified sequential therapy regimens for Helicobacter pylori eradication: A systematic review

Digestive and Liver Disease

Volumn 45, Issue 1, 2013, Pages 18-22

  Zullo, Angelo ^a   De Francesco, Vincenzo ^b   Hassan, Cesare ^a   Ridola, Lorenzo ^a   Repici, Alessandro ^c   Bruzzese, Vincenzo ^a   Vaira, Dino ^d  

^a NUOVO REGINA MARGHERITA HOSPITAL   (Italy)

^b Riuniti Hospital   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

H. pylori; Levofloxacin; Modified sequential therapy; Quinolones; Sequential therapy; Tetracycline

Indexed keywords

AMOXICILLIN; CIPROFLOXACIN; CLARITHROMYCIN; ESOMEPRAZOLE; FURAZOLIDONE; LANSOPRAZOLE; LEVOFLOXACIN; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; RABEPRAZOLE; TETRACYCLINE; TINIDAZOLE;

ANTIBIOTIC THERAPY; ARTICLE; DRUG EFFICACY; DRUG MEGADOSE; ERADICATION THERAPY; HELICOBACTER INFECTION; HUMAN; MODIFIED SEQUENTIAL THERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; DRUG THERAPY, COMBINATION; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; OFLOXACIN; TETRACYCLINE; TREATMENT OUTCOME;

EID: 84871614132     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2012.08.025     Document Type: Article

References (46)

1. Alakkari A., Zullo A., O'Connor H.J. Helicobacter pylori and nonmalignant diseases. Helicobacter 2011, 16(Suppl. 1):33-37.
2. Zullo A., Hassan C., Cristofari F., et al. Gastric low-grade mucosal-associated lymphoid tissue-lymphoma: Helicobacter pylori and beyond. World Journal of Gastrointestinal Oncology 2010, 2:181-186.
3. Stasi R., Sarpatwari A., Segal J.B., et al. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood 2009, 113:1231-1240.
4. Huang X., Qu X., Yan W., et al. Iron deficiency anemia can be improved after eradication of Helicobacter pylori. Postgraduate Medical Journal 2010, 86:272-278.
5. Chuah S.K., Tsay F.W., Hsu P.I., et al. A new look at anti-Helicobacter pylori therapy. World Journal of Gastroenterology 2011, 17:3971-3975.
6. Rokkas T., Sechopoulos P., Robotis I., et al. Cumulative H. pylori eradication rates in clinical practice by adopting first and second-line regimens proposed by the Maastricht III Consensus and a third-line empirical regimen. American Journal of Gastroenterology 2009, 104:21-25.
7. Zullo A., De Francesco V., Hassan C., et al. The sequential therapy regimen for Helicobacter pylori eradication: a pooled-data analysis. Gut 2007, 56:1353-1357.
8. Jafri N.S., Hornung C.A., Howden C.W. Meta-analysis: sequential therapy appears superior to standard therapy for Helicobacter pylori infection in patients naive to treatment. Annals of Internal Medicine 2008, 148:923-931.
9. Gatta L., Vakil N., Leandro G., et al. Sequential therapy or triple therapy for Helicobacter pylori infection: systematic review and meta-analysis of randomized controlled trials in adults and children. American Journal of Gastroenterology 2009, 104:3069-3079.
10. Tong J.L., Ran Z.H., Shen J., et al. Sequential therapy vs. standard triple therapies for Helicobacter pylori infection: a meta-analysis. Journal of Clinical Pharmacy and Therapeutics 2009, 34:41-53.
11. Vaira D., Zullo A., Hassan C., et al. The sequential therapy for Helicobacter pylori eradication: the time is now!. Therapeutic Advances in Gastroenterology 2009, 6:317-322.
12. Schmilovitz-Weiss H., Shalev T., Chechoulin Y., et al. High eradication rates of Helicobacter pylori infection following sequential therapy: the Israeli experience treating naïve patients. Helicobacter 2011, 16:229-233.
13. Albrecht P., Kotowska M., Szajewska H. Sequential therapy compared with standard triple therapy for Helicobacter pylori eradication in children: a double-blind, randomized, controlled trial. Journal of Pediatrics 2011, 159:45-49.
14. Fakheri H., Taghvaei T., Hosseini V., et al. A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial. Helicobacter 2001, 17:43-48.
15. Greenberg E.R., Anderson G.L., Morgan D.R., et al. 14-Day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial. Lancet 2011, 378:507-514.
16. Zullo A., Rinaldi V., Winn S., et al. A new highly effective short-term therapy schedule for Helicobacter pylori eradication. Alimentary Pharmacology and Therapeutics 2000, 14:715-718.
17. Cetinkaya Z.A., Sezikli M., Guzelbulut F., et al. Comparison of the efficacy of the two tetracycline-containing sequential therapy regimens for the eradication of Helicobacter pylori: 5 days versus 14 days amoxicillin. Helicobacter 2010, 15:143-147.
18. Yakut M., Cinar K., Seven G., et al. Sequential therapy for Helicobacter pylori eradication. Turkish Journal of Gastroenterology 2010, 21:206-211.
19. Sezgin O., Altintaş E., Nayir E., et al. A pilot study evaluating sequential administration of a PPI-amoxicillin followed by a PPI-metronidazole-tetracycline in Turkey. Helicobacter 2007, 12:629-632.
20. Uygun A., Kadayifci A., Yesilova Z., et al. Comparison of sequential and standard triple-drug regimen for Helicobacter pylori eradication: a 14-day, open-label, randomized, prospective, parallel-arm study in adult patients with nonulcer dyspepsia. Clinical Therapeutics 2008, 30:528-534.
21. Ataseven H., Demir M., Gen R. Effect of sequential treatment as a first-line therapy for Helicobacter pylori eradication in patients with diabetes mellitus. Southern Medical Journal 2010, 103:988-992.
22. Nadir I., Yonem O., Ozin Y., et al. Comparison of two different treatment protocols in Helicobacter pylori eradication. Southern Medical Journal 2011, 104:102-105.
23. Romano M., Cuomo A., Gravina G., et al. Empirical levofloxacin-containing versus clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomised trial. Gut 2010, 59:1465-1470.
24. Molina-Infante J., Perez-Gallardo B., Fernandez-Bermejo M., et al. Clinical trial: clarithromycin vs. levofloxacin in first-line triple and sequential regimens for Helicobacter pylori eradication. Alimentary Pharmacology and Therapeutics 2010, 31:1077-1084.
25. Ozdil K., Calhan T., Sahin A., et al. Levofloxacin based sequential and triple therapy compared with standard plus probiotic combination for Helicobacter pylori eradication. Hepato-Gastroenterology 2011, 58:1148-1152.
26. Polat Z., Kadayifci A., Kantarcioglu M., et al. Comparison of levofloxacin-containing sequential and standard triple therapies for the eradication of Helicobacter pylori. European Journal of Internal Medicine 2012, 23:165-168.
27. Aydin A., Oruc N., Turan I., et al. The modified sequential treatment regimen containing levofloxacin for Helicobacter pylori eradication in Turkey. Helicobacter 2009, 14:520-524.
28. Seyyedmajidi M., Falaknazi K., Mirsattari D., et al. Correlation between creatinine clearance and Helicobacter pylori infection eradication with sequential and triple therapeutic regimens: a randomised clinical trial. Arab Journal of Gastroenterology 2011, 12:150-153.
29. Aminian K., Farsad F., Ghanbari A., et al. A randomized trial comparing four Helicobacter pylori eradication regimens: standard triple therapy, ciprofloxacin based triple therapy, quadruple and sequential therapy. Tropical Gastroenterology 2010, 31:303-307.
30. Güzelbulut F., Sezikli M., çetinkaya Z., et al. Application of levofloxacin in the second phase of sequential therapy regimen for Helicobacter pylori eradication: is it a good choice?. Minerva Medica 2011, 102:171-176.
31. Federico A., Tardone G., Gravina A.G., et al. Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection. Gastroenterology 2012, 143:55-61.
32. Hsu P.I., Wu D.C., Wu J.Y., et al. Modified sequential Helicobacter pylori therapy: proton pump inhibitor and amoxicillin for 14 days with clarithromycin and metronidazole added as a quadruple (hybrid) therapy for the final 7 days. Helicobacter 2011, 16:139-145.
33. Hsu P.I., Wu D.C., Wu J.Y., et al. Is there a benefit to extending the duration of Helicobacter pylori sequential therapy to 14 days?. Helicobacter 2011, 16:146-152.
34. Paoluzi O.A., Visconti E., Andrei F., et al. Ten and eight-day sequential therapy in comparison to standard triple therapy for eradicating Helicobacter pylori infection: a randomized controlled study on efficacy and tolerability. Journal of Clinical Gastroenterology 2010, 44:261-266.
35. Valooran G.J., Kate V., Jagdish S., et al. Sequential therapy versus standard triple drug therapy for eradication of Helicobacter pylori in patients with perforated duodenal ulcer following simple closure. Scandinavian Journal of Gastroenterology 2011, 46:1045-1050.
36. Liou J.M., Chen C.C., Chen M.J., et al. Empirical modified sequential therapy containing levofloxacin and high-dose esomeprazole in second-line therapy for Helicobacter pylori infection: a multicentre clinical trial. Journal of Antimicrobial Chemotherapy 2011, 66:1847-1852.
37. Erdur B., Ozturk Y., Gurbuz E.D., et al. Comparison of sequential and standard therapy for Helicobacter pylori eradication in children and investigation of clarithromycin resistance. Journal of Pediatric Gastroenterology and Nutrition 2012, 29. [Epub ahead of print].
38. Riahizadeh S., Malekzadeh R., Agah S., et al. Sequential metronidazole-furazolidone or clarithromycin-furazolidone compared to clarithromycin-based quadruple regimens for the eradication of Helicobacter pylori in peptic ulcer disease: a double-blind randomized controlled trial. Helicobacter 2010, 15:497-504.
39. Gisbert J.P., Calvet X. Review article: the effectiveness of standard triple therapy for Helicobacter pylori has not changed over the last decade, but it is not good enough. Alimentary Pharmacology and Therapeutics 2011, 34:1255-1268.
40. Zullo A., Ierardi E., Hassan C., et al. Furazolidone-based terapie for Helicobacter pylori infection: a pooled-data analysis. Saudi Journal of Gastroenterology 2012, 18:11-17.
41. Gisbert J.P., Calvet X. Review article: non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pylori. Alimentary Pharmacology and Therapeutics 2011, 34:604-617.
42. Hassan C., De Francesco V., Zullo A., et al. Sequential treatment for Helicobacter pylori eradication in duodenal ulcer patients: improving the cost of pharmacotherapy. Alimentary Pharmacology and Therapeutics 2003, 18:641-646.
43. De Francesco V., Della Valle N., Stoppino V., et al. Effectiveness and pharmaceutical cost of sequential treatment for Helicobacter pylori in patients with non-ulcer dyspepsia. Alimentary Pharmacology and Therapeutics 2004, 19:993-998.
44. Zullo A., Hassan C., D'Ercole C., et al. Clarithromycin or levofloxacin in the sequential therapy for H. pylori eradication?. Alimentary Pharmacology and Therapeutics 2010, 31:1248-1249.
45. Zullo A., Hassan C., Cristofari F., et al. How to manage Helicobacter pylori after sequential therapy failure?. Journal of Clinical Gastroenterology 2010, 44:459-460.
46. Liou J.M., Lin J.T., Chang C.Y., et al. Levofloxacin-based and clarithromycin-based triple therapies as first-line and second-line treatments for Helicobacter pylori infection: a randomised comparative trial with crossover design. Gut 2010, 59:572-578.